ANNX Annexon Inc

Price (delayed)

$6.07

Market cap

$560.95M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.46

Enterprise value

$438.76M

Annexon is a clinical-stage biopharmaceutical company developing a pipeline of novel therapies for patients with classical complement-mediated disorders of the body, brain and eye. The company’s pipeline is based on ...

Highlights
Annexon's quick ratio has soared by 103% YoY and by 39% from the previous quarter
Annexon's EPS has increased by 39% YoY and by 18% QoQ

Key stats

What are the main financial stats of ANNX
Market
Shares outstanding
92.41M
Market cap
$560.95M
Enterprise value
$438.76M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
2.08
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Earnings
Revenue
$0
EBIT
-$120.74M
EBITDA
-$117.42M
Free cash flow
-$116.47M
Per share
EPS
-$1.46
Free cash flow per share
-$0.95
Book value per share
$2.91
Revenue per share
$0
TBVPS
$2.48
Balance sheet
Total assets
$304.07M
Total liabilities
$41.66M
Debt
$30.79M
Equity
$262.41M
Working capital
$257.61M
Liquidity
Debt to equity
0.12
Current ratio
20.62
Quick ratio
20.25
Net debt/EBITDA
1.04
Margins
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Efficiency
Return on assets
-46.5%
Return on equity
-56.5%
Return on invested capital
-102.7%
Return on capital employed
-41.5%
Return on sales
N/A
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

ANNX stock price

How has the Annexon stock price performed over time
Intraday
-1.78%
1 week
20.44%
1 month
13.25%
1 year
63.83%
YTD
33.7%
QTD
23.88%

Financial performance

How have Annexon's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$131.05M
Net income
-$120.74M
Gross margin
N/A
Net margin
N/A
The company's net income rose by 17% YoY and by 10% QoQ
The company's operating income rose by 13% YoY and by 9% QoQ

Growth

What is Annexon's growth rate over time

Valuation

What is Annexon stock price valuation
P/E
N/A
P/B
2.08
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Annexon's EPS has increased by 39% YoY and by 18% QoQ
The P/B is 63% higher than the last 4 quarters average of 1.3
The equity has grown by 22% year-on-year and by 4.7% since the previous quarter

Efficiency

How efficient is Annexon business performance
The return on invested capital has grown by 17% since the previous quarter and by 6% year-on-year
The ROE is up by 15% since the previous quarter and by 15% year-on-year
ANNX's ROA is up by 13% QoQ and by 13% YoY

Dividends

What is ANNX's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for ANNX.

Financial health

How did Annexon financials performed over time
Annexon's current ratio has soared by 103% YoY and by 40% from the previous quarter
Annexon's quick ratio has soared by 103% YoY and by 39% from the previous quarter
Annexon's debt is 88% less than its equity
The equity has grown by 22% year-on-year and by 4.7% since the previous quarter
The debt to equity has declined by 20% year-on-year and by 8% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.